0001145549-19-020550.txt : 20190705 0001145549-19-020550.hdr.sgml : 20190705 20190705140844 ACCESSION NUMBER: 0001145549-19-020550 CONFORMED SUBMISSION TYPE: N-CEN/A PUBLIC DOCUMENT COUNT: 3 CONFORMED PERIOD OF REPORT: 20181031 FILED AS OF DATE: 20190705 DATE AS OF CHANGE: 20190705 EFFECTIVENESS DATE: 20190705 FILER: COMPANY DATA: COMPANY CONFORMED NAME: JOHN HANCOCK INVESTMENT TRUST III CENTRAL INDEX KEY: 0000791271 IRS NUMBER: 000000000 STATE OF INCORPORATION: MA FISCAL YEAR END: 1031 FILING VALUES: FORM TYPE: N-CEN/A SEC ACT: 1940 Act SEC FILE NUMBER: 811-04630 FILM NUMBER: 19943667 BUSINESS ADDRESS: STREET 1: C/O JOHN HANCOCK FUNDS STREET 2: 200 BERKELEY STREET CITY: BOSTON STATE: MA ZIP: 02116 BUSINESS PHONE: 617-663-3000 MAIL ADDRESS: STREET 1: C/O JOHN HANCOCK FUNDS STREET 2: 200 BERKELEY STREET CITY: BOSTON STATE: MA ZIP: 02116 FORMER COMPANY: FORMER CONFORMED NAME: HANCOCK JOHN INVESTMENT TRUST III DATE OF NAME CHANGE: 19970501 FORMER COMPANY: FORMER CONFORMED NAME: FREEDOM INVESTMENT TRUST II DATE OF NAME CHANGE: 19930831 0000791271 S000000639 Greater China Opportunities Fund C000001829 Class A JCOAX C000001830 Class B JCOBX C000001831 Class C JCOCX C000001832 Class I JCOIX C000043937 Class NAV N-CEN/A 1 primary_doc.xml X0201 N-CEN/A 0001145549-19-000127 LIVE 0000791271 XXXXXXXX true false false N-1A true John Hancock Investment Trust III 811-04630 0000791271 549300WVETHR5GCOW962 200 Berkeley Street Boston 02116 US-MA US 617-663-4497 Citibank, N.A. 388 Greenwich Street New York 10013 8136041012 Citi maintains the accounting records and the custody of the assets. John Hancock Investment Trust III 200 Berkeley Street Boston 02116 6176634497 Records related to its functions as Registrant John Hancock Advisors, LLC 200 Berkeley Street Boston 02116 6176632430 Records related to its functions as advisor John Hancock Asset Management a division of Manulife Asset Management (North America) Limited 200 Bloor Street East Toronto CA M4W 1E5 4169263000 Records related to its functions as sub-advisor Y N N-1A 1 Y Hassell H. McClellan N/A N James R. Boyle N/A N Peter S. Burgess N/A N William H. Cunningham N/A N Grace K. Fey N/A N Marianne Harrison N/A Y Theron S. Hoffman N/A N Deborah C. Jackson N/A N James M. Oates N/A N Gregory A. Russo N/A N Steven R. Pruchansky N/A N Warren A. Thomson N/A Y Andrew G. Arnott N/A Y Charles L. Bardelis N/A N Francis V. Knox, Jr. N/A 200 Berkeley Street Boston 02116 XXXXXX N N N N N N John Hancock Funds, LLC 8-43582 000028262 N/A Y N PricewaterhouseCoopers LLP 00238 5493002GVO7EO8RNNS37 N N N N N N N Greater China Opportunities Fund S000000639 549300KQI3RTVG7N9U98 Y 5 0 0 N/A Y N N N N/A N/A N/A Rule 22d-1 (17 CFR 270.22d-1) Rule 32a-4 (17 CFR 270.32a-4) Y Y N N John Hancock Advisers, LLC 801-8124 000105790 AOWFNEEIG2OJ03AZXK87 N John Hancock Asset Management a division of Manulife Asset Management (North America) Limited N/A 000125142 549300LJ707JK4TLLK97 Y CA N John Hancock Signature Services, Inc. 084-01885 N/A Y N N Refinitiv 549300561UZND4C7B569 CA N ICE Data Services 5493000NQ9LYLDBCTL34 N Pricing Direct 549300WIC0TOJ7N7GD54 N IHS Markit N/A GB N Bloomberg LP N/A N Citibank N.A. E57ODZWZ7FF32TWEFA76 N N Citibank N.A. E57ODZWZ7FF32TWEFA76 N N Bank - section 17(f)(1) (15 U.S.C. 80a-17(f)(1)) Citibank Taiwan Limited FKT8632221BKH80JX336 TW N Y Foreign custodian - rule 17f-5 (17 CFR 270.17f-5) Citibank, N.A. N/A CN N Y Foreign custodian - rule 17f-5 (17 CFR 270.17f-5) N John Hancock Signature Services, Inc. 084-01885 SEC file number Y N N John Hancock Advisers, LLC AOWFNEEIG2OJ03AZXK87 Y N N John Hancock Funds, LLC 8-43582 000028262 N/A 49832.000000000000 Signator Investors, Inc. 8-13995 000000468 N/A 1548.000000000000 Credit Suisse AG N/A N/A ANGGYXNX0JLX3X63JN86 CH 16429.970000000000 Merrill Lynch, Pierce, Fenner & Smith Incorporated 8-7221 000007691 8NAV47T0Y26Q87Y0QP81 2482.220000000000 Morgan Stanley & Co. LLC 8-15869 000008209 9R7GPTSO7KV3UQJZQ078 11608.770000000000 Cathay Securities (Hong Kong) Limited N/A N/A 254900BOHSVZR4F6FA82 HK 11513.390000000000 J.P. Morgan Securities LLC 8-35008 000000079 ZBUT11V806EZRVTWT807 11308.170000000000 Credit Agricole SA N/A N/A 969500TJ5KRTCJQWXH05 FR 5590.190000000000 HSBC Bank PLC N/A N/A MP6I5ZYZBEU3UXPYFY54 GB 5184.350000000000 Citigroup Global Markets Holdings Inc. 8-8177 000007059 82VOJDD5PTRDMVVMGV31 5027.310000000000 BNP Paribas N/A N/A R0MUWSFPU8MPRO8K5P83 FR 4883.330000000000 Goldman Sachs & Co. LLC 8-129 000000361 FOR8UP27PHTHYVLBNG30 2766.000000000000 90527.810000000000 J.P. Morgan Securities LLC 8-35008 000000079 ZBUT11V806EZRVTWT807 13095475.730000000000 BNP Paribas N/A N/A R0MUWSFPU8MPRO8K5P83 FR 2594592.260000000000 Cathay Securities (Hong Kong) Limited N/A N/A 254900BOHSVZR4F6FA82 HK 11495756.920000000000 Credit Suisse AG N/A N/A ANGGYXNX0JLX3X63JN86 CH 9430210.270000000000 Goldman Sachs & Co. LLC 8-129 000000361 FOR8UP27PHTHYVLBNG30 5821572.450000000000 Morgan Stanley & Co. LLC 8-15869 000008209 9R7GPTSO7KV3UQJZQ078 4182593.960000000000 ITG Inc. 8-44218 000029299 549300S41SMIODVIT266 3387784.660000000000 Merrill Lynch, Pierce, Fenner & Smith Incorporated 8-7221 000007691 8NAV47T0Y26Q87Y0QP81 3155405.080000000000 HSBC Bank PLC N/A N/A MP6I5ZYZBEU3UXPYFY54 GB 2799491.610000000000 Credit Agricole SA N/A N/A 969500TJ5KRTCJQWXH05 FR 2682703.230000000000 72103927.990000000000 Y 63487540.000000000000 0.000000000000 Committed 275000000.000000000000 N Committed 112500000.000000000000 N Committed 112500000.000000000000 N Committed 100000000.000000000000 N Committed 75000000.000000000000 N Committed 75000000.000000000000 N N N true true INTERNAL CONTROL RPT 2 investtrustiiiic.htm AUDIT REPORT Form 8-K

Report of Independent Registered Public Accounting Firm

To the Board of Trustees of John Hancock Investment Trust III and Shareholders of John Hancock Greater China Opportunities Fund

In planning and performing our audit of the financial statements of John Hancock Greater China Opportunities Fund (the “Fund”) as of and for the year ended October 31, 2018, in accordance with the standards of the Public Company Accounting Oversight Board (United States) (“PCAOB”), we considered the Fund’s internal control over financial reporting, including controls over safeguarding securities, as a basis for designing our auditing procedures for the purpose of expressing our opinion on the financial statements and to comply with the requirements of Form N-CEN, but not for the purpose of expressing an opinion on the effectiveness of the Fund’s internal control over financial reporting. Accordingly, we do not express an opinion on the effectiveness of the Fund’s internal control over financial reporting.

The management of the Fund is responsible for establishing and maintaining effective internal control over financial reporting. In fulfilling this responsibility, estimates and judgments by management are required to assess the expected benefits and related costs of controls. A company’s internal control over financial reporting is a process designed to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles. A company’s internal control over financial reporting includes those policies and procedures that (1) pertain to the maintenance of records that, in reasonable detail, accurately and fairly reflect the transactions and dispositions of the assets of the company; (2) provide reasonable assurance that transactions are recorded as necessary to permit preparation of financial statements in accordance with generally accepted accounting principles, and that receipts and expenditures of the company are being made only in accordance with authorizations of management and directors of the company; and (3) provide reasonable assurance regarding prevention or timely detection of unauthorized acquisition, use or disposition of a company’s assets that could have a material effect on the financial statements.

Because of its inherent limitations, internal control over financial reporting may not prevent or detect misstatements. Also, projections of any evaluation of effectiveness to future periods are subject to the risk that controls may become inadequate because of changes in conditions, or that the degree of compliance with the policies or procedures may deteriorate.

A deficiency in internal control over financial reporting exists when the design or operation of a control does not allow management or employees, in the normal course of performing their assigned functions, to prevent or detect misstatements on a timely basis. A material weakness is a deficiency, or a combination of deficiencies, in internal control over financial reporting, such that there is a reasonable possibility that a material misstatement of the company’s annual or interim financial statements will not be prevented or detected on a timely basis.

Our consideration of the Fund’s internal control over financial reporting was for the limited purpose described in the first paragraph and would not necessarily disclose all deficiencies in internal control over financial reporting that might be material weaknesses under standards established by the PCAOB. However, we noted no deficiencies in the Fund’s internal control over financial reporting and its operation, including controls over safeguarding securities, that we consider to be material weaknesses as defined above as of October 31, 2018.


This report is intended solely for the information and use of the Board of Trustees of John Hancock Investment Trust III and the Securities and Exchange Commission and is not intended to be and should not be used by anyone other than these specified parties.

/s/ PricewaterhouseCoopers LLP

Boston, Massachusetts

December 18, 2018

 

2

EXEMPT ORDER INFO 3 exemptiveorder.htm IFL EXEMPTIVE ORDER Form 8-K

In regard to the Interfund Lending program, I certify that the Advisers on behalf of the Funds have implemented procedures reasonably designed to achieve compliance with the SEC Exemptive Order and Board approved procedures which includes the following objectives: (a) that the Interfund Loan Rate will be higher than the Repo Rate, but lower than the Bank Loan Rate; (b) compliance with the collateral requirements as set forth in the Application; (c) compliance with the percentage limitations on interfund borrowing and lending; (d) allocation of interfund borrowing and lending demand in an equitable manner and in accordance with procedures established by the Board; and (e) that the Interfund Loan Rate does not exceed the interest rate on any third-party borrowings of a borrowing John Hancock Fund at the time of the Interfund Loan.

 

/s/ Frank Knox

       
Frank Knox         Date: December 27, 2018
Chief Compliance Officer        
John Hancock Group of Funds